Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions

Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions

PURPOSE: To determine the patient-centered effectiveness of switching patients with persistent macular edema due to retinal vein occlusion (RVO) to aflibercept using the National Eye Institute Visual Function Questionnaire 25 (NEI-VFQ-25). MATERIALS AND METHODS: Prospective study of eyes with persis...

Full description

Bibliographic Details
Main Authors: Kimberly Spooner, Samantha Fraser-Bell, Thomas Hong, Andrew Chang
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Taiwan Journal of Ophthalmology
Subjects:
aflibercept
antivascular endothelial growth factor
macular edema
quality of life
retinal vein occlusion
treatment resistance
Online Access:http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=3;spage=244;epage=250;aulast=Spooner

Internet

http://www.e-tjo.org/article.asp?issn=2211-5056;year=2021;volume=11;issue=3;spage=244;epage=250;aulast=Spooner

Similar Items